The companies will collaborate to explore focused ultrasound in diagnostic and therapeutic applications for Alzheimer's disease (AD).
Cordance’s devices will be used to identify amyloid abnormalities in AD and investigate how focused ultrasound can enhance the distribution of Abyssinia's antibodies.